Jacob deGrom is giving the Rangers the full version of the Mets experience.
Now 38 and in year four of a five-year deal in Texas, with a chance to tack on a sixth, the former Mets ace still carries the kind of résumé that keeps him in the Hall of Fame conversation: a 2.63 career ERA and the best strikeout-to-walk ratio in MLB history at 5.38. But the same old deGrom storyline is back in play for the Rangers in 2026.
The right-hander has been on the mound enough to matter this season. After opening his Texas tenure with just 6 starts in year one and 3 in year two, he came back fully healthy last year and posted a 2.97 ERA.
This season, he’s been a steady presence again, going 7-5 with a 3.49 ERA across 18 starts. The problem is what comes next: the Rangers don’t know when his next outing will be because of a mild left glute strain that could send him to the IL.
Texas is downplaying it, and deGrom said the issue is something he believes he can pitch through.
“I told [a team doctor] it’s something I can pitch with, and he’s like, ‘Yeah, it’s in an area where it’s not really going to get worse, it’s just what you can deal with.’ I said I can deal with it right now, and then the discussion becomes, do we take this extra time because we have it?”
That’s where the caution flag comes in. DeGrom has already shown the Rangers how quickly a situation can turn.
His final start for the 2021 Mets came on July 7, and that was also his last outing for Texas in that stretch. The injury then was to his arm, and while the initial outlook didn’t sound disastrous, he didn’t pitch in another MLB game until August 2 of the following season.
The lesson for Texas is obvious: just because deGrom can go out there doesn’t mean he should. This injury isn’t the same as the one that ended his 2021 Mets season, but the danger is familiar. If he compensates in another area while trying to push through, the Rangers could wind up with a new problem instead of a manageable one.
There’s also the workload to consider. With his most recent start, deGrom crossed 100 innings for only the second time since 2019.
The other time was last year. His 2021 season ended at 92 innings over 15 starts.
And the timing of those final first-half starts still feels strange in hindsight.
Texas signed deGrom to a massive contract expecting impact, and the missing time has kept that from fully happening. This season, even without peak deGrom stuff, had a chance to be the most satisfying one yet.
The Rangers entered the day 46-38 with a 4.5-game lead over the Washington Nationals. They finished 77-85 without deGrom.
Rangers fans, October plans may need a warning label.
In Other News...
The Mets Have Made This Painful All-Star Move Five Times
The Mets history with in-season All-Star trades is a reminder that even a player having a star turn in one summer can still become part of a deadline deal before the year is out. Since 1992, the club has moved five All-Stars in the same season they were selected, a list that stretches from David Cone and Bobby Bonilla in the early 1990s to Rick Reed and Armando Benitez in the 2000s and Carlos Beltran in 2011.
Each one carried its own kind of sting, because these were not fringe pieces but players who had already earned league-wide recognition before the Mets decided to cash them in. Some of those moves were made with an eye toward the future, others with a sense that the present had already slipped away, and the long view has made a few of them look even more consequential in hindsight. [Read more 🡒]
How Mets Futures Game Prospects Really Turned Out Over Time
Since the All-Star Futures Game began, the Mets have had a long enough run of prospects through it to tell a pretty revealing story about how talent travels. Some of those names turned into core pieces in Queens, others were flipped in deals that changed the roster, and plenty simply never became what the organization once hoped, which is the nature of any prospect list that stretches across eras.
The more recent group keeps that same mix of promise and uncertainty. Francisco Alvarez and Carson Benge are already on the MLB roster, while Jonah Tong and Ryan Clifford are still in the part of the story where projection matters more than proof, and the next few seasons will decide whether they join the Mets success side of the ledger or become part of the long list of what-ifs. [Read more 🡒]